Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of CAPLIN POINT. For more details, see the CAPLIN POINT quarterly results and CAPLIN POINT share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.5 |
No. of shares | m | 75.94 |
1 Week | % | 2.8 |
1 Month | % | 7.5 |
1 Year | % | 106.1 |
52 week H/L | Rs | 1,617.8/647.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
CAPLIN POINT EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 623 | 466 | 686 | 1,034 | 856 | |
Low | Rs | 305 | 180 | 264 | 407 | 575 | |
Sales per share (Unadj.) | Rs | 85.8 | 114.1 | 140.3 | 167.5 | 193.2 | |
Earnings per share (Unadj.) | Rs | 23.3 | 28.4 | 33.2 | 40.7 | 49.7 | |
Diluted earnings per share | Rs | 23.2 | 28.3 | 33.1 | 40.6 | 49.6 | |
Cash flow per share (Unadj.) | Rs | 26.4 | 32.6 | 38.1 | 46.9 | 55.6 | |
Dividends per share (Unadj.) | Rs | 2.20 | 2.50 | 3.00 | 4.00 | 4.50 | |
Adj. dividends per share | Rs | 2.19 | 2.49 | 2.99 | 3.99 | 4.50 | |
Avg Dividend yield | % | 0.5 | 0.8 | 0.6 | 0.6 | 0.6 | |
Book value per share (Unadj.) | Rs | 82.8 | 124.1 | 154.8 | 193.8 | 245.7 | |
Adj. book value per share | Rs | 82.4 | 123.6 | 154.2 | 193.4 | 245.6 | |
Shares outstanding (eoy) | m | 75.63 | 75.64 | 75.64 | 75.79 | 75.90 | |
Price / Sales ratio | x | 5.4 | 2.8 | 3.4 | 4.3 | 3.7 | |
Avg P/E ratio | x | 19.9 | 11.4 | 14.3 | 17.7 | 14.4 | |
P/CF ratio (eoy) | x | 17.5 | 9.9 | 12.5 | 15.4 | 12.9 | |
Price / Book Value ratio | x | 5.6 | 2.6 | 3.1 | 3.7 | 2.9 | |
Dividend payout | % | 9.4 | 8.8 | 9.0 | 9.8 | 9.1 | |
Avg Mkt Cap | Rs m | 35,066 | 24,433 | 35,930 | 54,593 | 54,308 | |
Total wages/salary | Rs m | 456 | 671 | 1,020 | 1,147 | 1,361 |
CAPLIN POINT INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 6,487 | 8,632 | 10,613 | 12,694 | 14,667 | |
Other income | Rs m | 190 | 413 | 279 | 389 | 565 | |
Total revenues | Rs m | 6,677 | 9,045 | 10,892 | 13,083 | 15,233 | |
Gross profit | Rs m | 2,319 | 2,601 | 3,243 | 3,945 | 4,406 | |
Depreciation | Rs m | 234 | 316 | 370 | 469 | 450 | |
Interest | Rs m | 6 | 3 | 16 | 7 | 8 | |
Profit before tax | Rs m | 2,269 | 2,695 | 3,136 | 3,858 | 4,514 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 503 | 544 | 622 | 774 | 744 | |
Profit after tax | Rs m | 1,766 | 2,151 | 2,514 | 3,085 | 3,770 | |
Gross profit margin | % | 35.7 | 30.1 | 30.6 | 31.1 | 30.0 | |
Effective tax rate | % | 22.2 | 20.2 | 19.8 | 20.1 | 16.5 | |
Net profit margin | % | 27.2 | 24.9 | 23.7 | 24.3 | 25.7 |
CAPLIN POINT BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 4,937 | 8,225 | 10,146 | 12,978 | 15,545 | |
Current liabilities | Rs m | 861 | 1,443 | 1,429 | 2,077 | 2,680 | |
Net working cap to sales | % | 62.8 | 78.6 | 82.1 | 85.9 | 87.7 | |
Current ratio | x | 5.7 | 5.7 | 7.1 | 6.2 | 5.8 | |
Inventory Days | Days | 46 | 30 | 14 | 52 | 70 | |
Debtors Days | Days | 899 | 968 | 10 | 9 | 10 | |
Net fixed assets | Rs m | 2,488 | 3,032 | 3,490 | 4,323 | 6,231 | |
Share capital | Rs m | 510 | 897 | 897 | 897 | 898 | |
"Free" reserves | Rs m | 5,750 | 8,488 | 10,813 | 13,787 | 17,754 | |
Net worth | Rs m | 6,261 | 9,385 | 11,710 | 14,685 | 18,651 | |
Long term debt | Rs m | 3 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 7,425 | 11,258 | 13,636 | 17,301 | 21,776 | |
Interest coverage | x | 391.5 | 843.1 | 198.2 | 552.2 | 579.7 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.9 | 0.8 | 0.8 | 0.7 | 0.7 | |
Return on assets | % | 23.9 | 19.1 | 18.6 | 17.9 | 17.3 | |
Return on equity | % | 28.2 | 22.9 | 21.5 | 21.0 | 20.2 | |
Return on capital | % | 36.3 | 28.7 | 26.9 | 26.3 | 24.2 | |
Exports to sales | % | 78.4 | 57.2 | 44.4 | 39.1 | 32.8 | |
Imports to sales | % | 11.8 | 8.0 | 3.1 | 2.5 | 1.7 | |
Exports (fob) | Rs m | 5,087 | 4,941 | 4,713 | 4,966 | 4,804 | |
Imports (cif) | Rs m | 768 | 687 | 333 | 312 | 243 | |
Fx inflow | Rs m | 5,087 | 4,941 | 4,713 | 4,966 | 4,804 | |
Fx outflow | Rs m | 964 | 807 | 333 | 312 | 243 | |
Net fx | Rs m | 4,123 | 4,134 | 4,379 | 4,654 | 4,561 |
CAPLIN POINT CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 834 | 447 | 2,686 | 3,367 | 2,714 | |
From Investments | Rs m | -1,005 | -545 | -294 | -3,768 | -2,176 | |
From Financial Activity | Rs m | 898 | 798 | -240 | -407 | -282 | |
Net Cashflow | Rs m | 735 | 701 | 2,150 | -808 | 268 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: C C Paarthipan | COMP SEC: Dinesh RG | YEAR OF INC: 1990 | BSE CODE: 524742 | FV (Rs): 2 | DIV YIELD (%): 0.3 |
Read: CAPLIN POINT 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare CAPLIN POINT With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.